What are the implications of low C-peptide levels on treatment options and outcomes for patients with type 2 diabetes mellitus?
Low C-peptide levels in type 2 diabetes mellitus patients indicate reduced insulin secretion capacity and influence treatment decisions, leaning towards strategies common in type 1 diabetes like automated insulin delivery. Further research is needed to directly address treatment efficacy in low C-peptide T2DM populations.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-03
- DOI
- https://doi.org/10.5281/zenodo.23919076
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00